Reference number : 172-2020-2021-Q1-952346, amendment number : , agreement type : C, recipient legal name : Innovakine Therapeutics Inc., recipient country : CA, recipient province : BC, recipient city : Vancouver|Vancouver, recipient postal code : V7X 1L3, program name english : Industrial Research Assistance Program – Contributions to Firms, program name french : Programme d’aide à la recherche industrielle – Contributions aux entreprises, program purpose english : The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization, program purpose french : Le PARI, par le biais des Contributions aux entreprises, vise à appuyer la recherche, le développement, l’adaptation et/ou l’adoption au Canada de produits, de services ou de processus novateurs ou axés sur des technologies nouvelles ou améliorées, et ce jusqu’à leur commercialisation, agreement title english : Cellular Therapy Market Assessment, agreement title french : Évaluation du marché de la thérapie cellulaire, agreement number : 952346, agreement value : 20000.0, agreement start date : 2020-06-08, agreement end date : 2020-09-13, description english : Innovakine has developed an innovative platform technology with the potential to enhance the efficacy and safety of engineered cell therapies across multiple disease indications, including cancer, infectious disease, autoimmunity, transplantation and regenerative medicine. The current project will constitute a competitive landscape analysis that will enable Innovakine to prioritize the most promising medical and commercial applications of its technology., description french : Innovakine a mis au point une plateforme technologique novatrice susceptible d'améliorer l'efficacité et la sécurité des thérapies cellulaires artificielles dans de multiples indications de maladies, notamment le cancer, les maladies infectieuses, l'auto-immunité, la transplantation et la médecine régénérative. Le projet actuel constituera une analyse du contexte concurrentiel qui permettra à Innovakine de donner la priorité aux applications médicales et commerciales les plus prometteuses de sa technologie., expected results english : The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization, expected results french : Le PARI, par le biais des Contributions aux entreprises, vise à appuyer la recherche, le développement, l’adaptation et/ou l’adoption au Canada de produits, de services ou de processus novateurs ou axés sur des technologies nouvelles ou améliorées, et ce jusqu’à leur commercialisation, additional information english : nan, additional information french : nan, owner organization : nrc-cnrc, owner organization title : National Research Council Canada | Conseil national de recherches Canada